Idenix Pharmaceuticals (IDIX)
Idenix Pharmaceuticals Key Statistics
Pro Data ExportCurrent Valuation
Dividends and Shares
| Dividend | |
| Dividend Yield | 0.00% |
| Cash Div. Payout Ratio TTM Pro | Go Pro |
| Payout Ratio TTM Pro | Go Pro |
| Dividend Date | |
| Ex-Dividend Date | |
| Last Split Factor | |
| Last Split Date |
Profitability
| Gross Profit Margin | 96.72% |
| EBITDA Margin TTM Pro | Go Pro |
| Operating Margin TTM Pro | Go Pro |
| Profit Margin | 32.12% |
Management Effectiveness
Liquidity and Solvency
| Altman Z-Score Pro | Go Pro |
| Current Ratio | 5.898 |
| Debt to Equity Ratio | 0.1469 |
| KZ Index Pro | Go Pro |
| Tangible Common Equity Ratio Pro | Go Pro |
| Times Interest Earned TTM Pro | Go Pro |
Stock Price Performance
| Beta Pro | Go Pro |
| 1 Month Stock Returns | 10.06% |
| Year to Date Stock Returns | 26.39% |
| 1 Year Stock Returns | 102.8% |
| 3 Year Stock Returns | 176.8% |
| 52 Week High | 15.25 |
| 52 Week Low | 4.03 |
Income Statement
| Revenues TTM | 38.60M |
| Revenue Per Share TTM | 0.3587 |
| Revenue Growth | 790.9% |
| Gross Profit TTM | 35.65M |
| EBITDA TTM Pro | Go Pro |
| Income from Cont. Ops Pro | Go Pro |
| Net Income TTM | -32.29M |
| Earnings Per Share TTM | -0.36 |
| Other Comprehensive Income Pro | Go Pro |
Cash Flow Statement
| Cash Investing TTM | -0.603M |
| Cash Financing TTM | 131.61M |
| Cash Operations TTM | -56.97M |
| Capital Expenditures | 0.371M |
Share Statistics
| Shares Outstanding | 107.59M |
Balance Sheet
| Cash and ST Investments | 105.26M |
| Total Assets | 127.14M |
| Liabilities | 56.16M |
| Book Value | 70.99M |
| Book Value per Share | 0.6598 |
| Tangible Book Value Pro | Go Pro |
| Tangible Book Value Per Share Pro | Go Pro |
| Long Term Debt | 10.43M |
Earnings Quality
| Accruals Pro | Go Pro |
| Beneish M-Score Pro | Go Pro |
You may also be interested in these IDIX related companies
IDIX News
$IDIX looks like the 12.5 17.5 spread is due 2 possible $6/share bump if $GILD settles on Hep. C drug...interesting
about 12 hours ago by johnkelly
about 12 hours ago by johnkelly
$IDIX http://stks.co/40Ve Price broke through the falling trendline from January and strong resistance at 9.50.
about 21 hours ago by BuyOnStrength
about 21 hours ago by BuyOnStrength
$IDIX http://stks.co/40Vb Price bounced from two long-term trendlines forming an interim bottom.
about 21 hours ago by BuyOnStrength
about 21 hours ago by BuyOnStrength
@johnkelly $IDIX Montruous activity today as well, something is going on.
about 4 days ago by littleguy
about 4 days ago by littleguy
thu $IDIX hype seemz 2 have reeturned. huge call volume on OTM callz yesterday. pickin up sum ITMs 2day
about 5 days ago by johnkelly
about 5 days ago by johnkelly
$IDIX HighGrowthFinancial told me a few weeks ago after it hit 9.35 and went back to 785ish that the chart looked good and dont worry.
about 5 days ago by GArgondizza
about 5 days ago by GArgondizza
$IDIX Option Bulls Take Another Shot on Idenix. Pete Najarian. http://stks.co/3zAL
about 5 days ago by littleguy
about 5 days ago by littleguy
$IDIX Any buyout talk? I'd like to hit the INHX, Pharmasset, Idenix trifecta. Nobody likes Hep C more than me
about 5 days ago by Grossgrossgross
about 5 days ago by Grossgrossgross
$IDIX where is EXP. yeah. Calls expired worthless a while ago but long 3000 shares in the 11's
about 5 days ago by PeruvianKnightmare
about 5 days ago by PeruvianKnightmare
$IDIX still marching, spending more confirmation time on da BULLS side
about 5 days ago by HighGrowthFinancial
about 5 days ago by HighGrowthFinancial
Brean Murray Sees Recent Upside in Idenix (IDIX) Related to Possible Gilead (GILD) Settlement in June
May 24, 5:14PM Street Insider
May 24, 5:14PM Street Insider
@GArgondizza @johnkelly Why the love affair with $IDIX today? Don't see any news pending.
about 5 days ago by PattyA_F
about 5 days ago by PattyA_F
$IDIX Getting a bit extended! Be careful, stay disciplined! http://chart.ly/veumy3r
about 5 days ago by TeejTime2
about 5 days ago by TeejTime2
Idenix Pharmaceuticals' CEO Presents at Deutsche Bank 37th Annual Healthcare Conference (Transcript)
May 07, 7:46PM Seeking Alpha
May 07, 7:46PM Seeking Alpha
Idenix Pharmaceuticals Reports First Quarter 2012 Financial Results and HCV Development Program Progress
May 02, 4:05PM GlobeNewswire
May 02, 4:05PM GlobeNewswire
Idenix Pharma (IDIX) Rips, Reports Encouraging Data from IDX719 Phase I
Apr 19, 9:21AM Street Insider
Apr 19, 9:21AM Street Insider
Idenix Pharmaceuticals Provides Update on Hepatitis C Clinical Development Programs
Apr 19, 7:53AM Benzinga
Apr 19, 7:53AM Benzinga
Credit Suisse Assumes Coverage on Idenix Pharmaceuticals Inc. (IDIX) at Neutral
Apr 17, 7:47AM Street Insider
Apr 17, 7:47AM Street Insider
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| IDIX | 9.41 | -0.27 | -2.79% | 1.041B |
| IDI | 1.85 | -0.03 | -1.60% | 38.59M |
| IDCC | 25.28 | +0.14 | +0.56% | 1.134B |
| IDA | 39.30 | +0.17 | +0.43% | 1.955B |
| ICUI | 52.22 | +0.21 | +0.40% | 722.94M |
| ICS | 15.36 | +0.07 | +0.46% | |
| ICON | 15.86 | +0.38 | +2.45% | 1.123B |
| ICLR | 21.90 | -0.03 | -0.14% | 1.319B |
| ICH | 4.11 | -0.05 | -1.20% | 29.91M |
| ICGE | 8.82 | +0.03 | +0.34% | 329.98M |
